REGENXBIO Inc. (RGNX) Form 8-K — Oct 16, 2026
REGENXBIO director Kenneth T. Mills resigned from the board effective October 21, 2026, citing his recent appointment as CEO of another company. The filing states his decision was unrelated to any disagreement with the company's operations, policies, or practices. In connection with the departure, the board appointed George Migausky as Chairman, and Daniel Tassé stepped down as Lead Independent Director while remaining a director.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.